Introduction of new technologies in orthopaedic surgery

Stuart B. Goodman, William Mihalko, Paul A. Anderson, Katherine Sale, Kevin J. Bozic

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The introduction of new devices, biologics, and combination products to the orthopaedic marketplace is increasing rapidly. The majority of these new technologies obtain clearance to market by demonstrating substantial equivalence to a predicate (previously approved device) according to the U.S. Food and Drug Administration (FDA) 510(k) process. Surgeons play a critical role in the introduction of new technologies to patients and must take a leadership role in promoting safe, efficacious, appropriate, and cost-effective care, especially for operative procedures. Surgeons should monitor and document their patients' clinical outcomes and adverse events when using new technology, to ensure that the new technology is performing as desired.

Original languageEnglish (US)
Article number00067
JournalJBJS Reviews
Volume4
Issue number5
DOIs
StatePublished - May 17 2016

Fingerprint

Orthopedics
Technology
Equipment and Supplies
Operative Surgical Procedures
United States Food and Drug Administration
Biological Products
Costs and Cost Analysis
Surgeons

All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Goodman, S. B., Mihalko, W., Anderson, P. A., Sale, K., & Bozic, K. J. (2016). Introduction of new technologies in orthopaedic surgery. JBJS Reviews, 4(5), [00067]. https://doi.org/10.2106/JBJS.RVW.O.00067

Introduction of new technologies in orthopaedic surgery. / Goodman, Stuart B.; Mihalko, William; Anderson, Paul A.; Sale, Katherine; Bozic, Kevin J.

In: JBJS Reviews, Vol. 4, No. 5, 00067, 17.05.2016.

Research output: Contribution to journalReview article

Goodman, SB, Mihalko, W, Anderson, PA, Sale, K & Bozic, KJ 2016, 'Introduction of new technologies in orthopaedic surgery', JBJS Reviews, vol. 4, no. 5, 00067. https://doi.org/10.2106/JBJS.RVW.O.00067
Goodman, Stuart B. ; Mihalko, William ; Anderson, Paul A. ; Sale, Katherine ; Bozic, Kevin J. / Introduction of new technologies in orthopaedic surgery. In: JBJS Reviews. 2016 ; Vol. 4, No. 5.
@article{b990e2b26f1242d29550a3901eee4655,
title = "Introduction of new technologies in orthopaedic surgery",
abstract = "The introduction of new devices, biologics, and combination products to the orthopaedic marketplace is increasing rapidly. The majority of these new technologies obtain clearance to market by demonstrating substantial equivalence to a predicate (previously approved device) according to the U.S. Food and Drug Administration (FDA) 510(k) process. Surgeons play a critical role in the introduction of new technologies to patients and must take a leadership role in promoting safe, efficacious, appropriate, and cost-effective care, especially for operative procedures. Surgeons should monitor and document their patients' clinical outcomes and adverse events when using new technology, to ensure that the new technology is performing as desired.",
author = "Goodman, {Stuart B.} and William Mihalko and Anderson, {Paul A.} and Katherine Sale and Bozic, {Kevin J.}",
year = "2016",
month = "5",
day = "17",
doi = "10.2106/JBJS.RVW.O.00067",
language = "English (US)",
volume = "4",
journal = "JBJS Reviews",
issn = "2329-9185",
publisher = "Journal of Bone and Joint Surgery Inc.",
number = "5",

}

TY - JOUR

T1 - Introduction of new technologies in orthopaedic surgery

AU - Goodman, Stuart B.

AU - Mihalko, William

AU - Anderson, Paul A.

AU - Sale, Katherine

AU - Bozic, Kevin J.

PY - 2016/5/17

Y1 - 2016/5/17

N2 - The introduction of new devices, biologics, and combination products to the orthopaedic marketplace is increasing rapidly. The majority of these new technologies obtain clearance to market by demonstrating substantial equivalence to a predicate (previously approved device) according to the U.S. Food and Drug Administration (FDA) 510(k) process. Surgeons play a critical role in the introduction of new technologies to patients and must take a leadership role in promoting safe, efficacious, appropriate, and cost-effective care, especially for operative procedures. Surgeons should monitor and document their patients' clinical outcomes and adverse events when using new technology, to ensure that the new technology is performing as desired.

AB - The introduction of new devices, biologics, and combination products to the orthopaedic marketplace is increasing rapidly. The majority of these new technologies obtain clearance to market by demonstrating substantial equivalence to a predicate (previously approved device) according to the U.S. Food and Drug Administration (FDA) 510(k) process. Surgeons play a critical role in the introduction of new technologies to patients and must take a leadership role in promoting safe, efficacious, appropriate, and cost-effective care, especially for operative procedures. Surgeons should monitor and document their patients' clinical outcomes and adverse events when using new technology, to ensure that the new technology is performing as desired.

UR - http://www.scopus.com/inward/record.url?scp=85029014348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029014348&partnerID=8YFLogxK

U2 - 10.2106/JBJS.RVW.O.00067

DO - 10.2106/JBJS.RVW.O.00067

M3 - Review article

VL - 4

JO - JBJS Reviews

JF - JBJS Reviews

SN - 2329-9185

IS - 5

M1 - 00067

ER -